文献速递创伤骨科骨质疏松与代谢性骨病

亚洲骨质疏松性髋部骨折的经济负担:系统综述

Economic burden of osteoporosis-related hip fracture in Asia: a systematic review.
PubMed 文献 · Osteoporos Int · 2017-03-17

本系统综述检索2000至2015年PubMed、EMBASE和EBSCOHost数据库,分析亚洲骨质疏松性髋部骨折的医疗费用。仅15篇文章符合纳入标准,髋部骨折治疗费用从774美元至14198.90美元不等(中位数2943新加坡元),平均占各国2014年人均GDP的18.95%(范围3.58%-57.05%)。纳入研究中约40%报告费用超过人均GDP的三分之一。

要点

  • 亚洲髋部骨折经济负担研究严重缺乏,仅15篇符合纳入标准。
  • 髋部骨折治疗费用从774美元至14198.90美元(中位数2943新加坡元)。
  • 费用平均占各国2014年人均GDP的18.95%(范围3.58%-57.05%)。

核心结论

  • 亚洲地区骨质疏松疾病负担研究匮乏,现有少数研究在评估经济负担的方法学上缺乏标准化。
  • 需要鼓励更多高质量的骨质疏松疾病负担研究,以为政策制定者的医疗规划提供依据。

研究设计与样本

  • 系统综述,检索PubMed、EMBASE和EBSCOHost数据库中2000年至2015年的文章。
  • 纳入分析髋部骨折相关医疗费用、费用构成和住院时长的研究,并对研究设计进行定性分析。

主要发现

  • 仅15篇文章符合纳入标准,其中只有两项研究报告了包括间接或无形费用在内的全面费用。
  • 大多数研究对经济评价的实施标准报告令人满意,但方法学设计存在很大差异。
  • 髋部骨折治疗费用从774美元至14198.90美元(中位数2943新加坡元),平均占各国2014年人均GDP的18.95%(范围3.58%-57.05%)。
  • 约40%的纳入研究报告髋部骨折治疗费用超过人均GDP的三分之一。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 亚洲关于髋部骨折经济负担的已发表研究严重缺乏,仅15篇文章符合纳入标准。
  • 即使纳入的研究中,也只有两项报告了包括间接或无形费用在内的全面费用。
  • 研究的方法学设计存在很大差异。
  • 由于研究设计和其他影响因素,髋部骨折治疗费用存在很大变异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: This review analyzes the economic costs of HF in Asia. The availability and quality of studies on the burden of osteoporosis in Asia are very scarce. There is a need to encourage more quality cost of osteoporosis studies based on standardized methods to convince healthcare authorities in implementing appropriate strategies. INTRODUCTION: Osteoporosis fractures, especially hip fractures, impose large economic costs to governments and societies. This review aimed to systematically analyze available evidence on healthcare costs associated with osteoporosis-related hip fractures (HF) in Asia. METHODS: Articles were systematically sought from databases including PubMed, EMBASE, and EBSCOHost between 2000 and 2015. Total costs associated with HF care, the cost components, and length of stays were retrieved and analyzed. Study designs were also qualitatively analyzed. RESULTS: The availability of published studies on economic burden of HF in Asia is severely lacking with only 15 articles met the inclusion criteria. Even among the included studies, only two studies reported comprehensive costs evaluating all costs including indirect or intangible costs. Most studies satisfactorily reported criteria for conducting economic evaluation, but large variations existed in the methodological design. Due to study design and other influencing factors, large variation in the cost of HF treatment from US$774 to US$14,198.90 (median S$2943), representing an average of 18.95% (range: 3.58-57.05%) of the countries' 2014 GDP/capita, was observed. This highlighted the heavy burden of managing HF in Asia with about 40% of the included studies reported using more than one third of GDP/capita. CONCLUSION: There is a paucity of burden of illness studies of osteoporosis in the Asian region. For the few available studies, there was a lack of standardization in methodological approach in evaluating the economic burden of the disease. There is a need to encourage more quality burden of illness studies of osteoporosis to inform policymakers in healthcare planning.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Mohd-Tahir NA, Li SC. Economic burden of osteoporosis-related hip fracture in Asia: a systematic review. Osteoporos Int. 2017. PMID: 28314898. doi:10.1007/s00198-017-3985-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。